Results 191 to 199 of about 1,482,753 (199)

The Imperative to Treat Tobacco Use Disorder

Psychiatric Services
Emily, Kager, Joseph, Kim, Peter, Spyrou, Lisa B, Dixon   +3 more
openaire   +2 more sources

Co-morbid tobacco use disorder and depression: A re-evaluation of smoking cessation therapy in depressed smokers.

American Journal on Addictions, 2015
Marya Morozova, Rachel A Rabin, T. George   +2 more
semanticscholar   +1 more source

Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder.

Journal of Affective Disorders, 2015
S. Nunes, Luiz Gustavo Piccoli de Melo, Márcia Regina Pizzo de Castro, D. Barbosa, H. Vargas, M. Berk, M. Maes   +6 more
semanticscholar   +1 more source

Tobacco use disorder and other mental disorders: The neglected dual disorder

Spanish Journal of Psychiatry and Mental Health
Parro-Torres C, Casas M, Martínez-Raga J, Cristina Pinet Ogué M, Martínez PAS, Szerman N   +5 more
openaire   +3 more sources

Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.

Journal of Affective Disorders, 2015
C. Bortolasci, H. Vargas, Sandra Odebrecht Vargas Nunes, Luiz Gustavo Piccoli de Melo, Márcia Regina Pizzo de Castro, E. Moreira, S. Dodd, D. Barbosa, M. Berk, M. Maes   +9 more
semanticscholar   +1 more source

The relationship between tobacco use and mental disorders

Current Opinion in Psychiatry, 1999
openaire   +2 more sources

Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort

European Archives of Psychiatry and Clinical Neuroscience, 2019
J. Mallet, Y. Strat, F. Schürhoff, N. Mazer, C. Portalier, M. Andrianarisoa, B. Aouizerate, F. Berna, L. Brunel, D. Capdevielle, I. Chéreau, T. D’amato, J. Dubreucq, C. Faget, F. Gabayet, R. Honciuc, C. Lançon, P. Llorca, D. Misdrahi, R. Rey, P. Roux, A. Schandrin, M. Urbach, P. Vidailhet, G. Fond, C. Dubertret, M. Andrianarisoa, B. Aouizerate, N. Bazin, F. Berna, O. Blanc, L. Brunel, E. Bulzacka, D. Capdevielle, I. Chéreau-Boudet, G. Chesnoy-Servanin, Coulon Nathalie, J. Danion, T. D’amato, A. Deloge, C. Delorme, H. Denizot, J. Dorey, C. Dubertret, J. Dubreucq, C. Faget, C. Fluttaz, G. Fond, S. Fonteneau, F. Gabayet, E. Giraud-Baro, D. Lacelle, C. Lançon, H. Laouamri, M. Leboyer, T. L. Gloahec, Y. Strat, P. Llorca, J. Mallet, E. Metairie, D. Misdrahi, I. Offerlin-Meyer, C. Passerieux, P. Péri, S. Pires, C. Portalier, L. Ramet, R. Rey, C. Roman, A. Schandrin, F. Schürhoff, A. Tessier, A. Tronche, M. Urbach, F. Vaillant, A. Vehier, P. Vidailhet, E. Vilà, H. Yazbek, A. Zinetti-Bertschy   +79 more
semanticscholar   +1 more source

Pharmacological treatment of tobacco use disorder.

2019
openaire   +1 more source

Tobacco use disorder and depression: emerging strategies and recommendations:

Expert Review of Neurotherapeutics
openaire   +2 more sources